SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-037345
Filing Date
2020-02-14
Accepted
2020-02-14 12:01:02
Documents
3
Group Members
ANNE-MARI PASTEROMEGA FUND IV GP MANAGER, LTD.OMEGA FUND IV GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d885388dsc13ga.htm SC 13G/A 115981
2 EX-99.1 d885388dex991.htm EX-99.1 7253
3 EX-99.2 d885388dex992.htm EX-99.2 11094
  Complete submission text file 0001193125-20-037345.txt   135961
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-88939 | Film No.: 20616319
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences